View ValuationOptiCept Technologies 향후 성장Future 기준 점검 5/6OptiCept Technologies (는) 각각 연간 105.4% 및 26.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 109.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 4.9% 로 예상됩니다.핵심 정보105.4%이익 성장률109.14%EPS 성장률Machinery 이익 성장24.8%매출 성장률26.4%향후 자기자본이익률4.90%애널리스트 커버리지Low마지막 업데이트31 Mar 2026최근 향후 성장 업데이트Breakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.Breakeven Date Change • Oct 21Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 51% per year to 2025. The company is expected to make a profit of kr1.85m in 2026. Average annual earnings growth of 87% is required to achieve expected profit on schedule.Breakeven Date Change • Jun 05Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 60% per year to 2025. The company is expected to make a profit of kr6.00m in 2026. Average annual earnings growth of 82% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 08Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests the company will make a profit of kr40.0m in 2021. Earnings growth of 89% is required to achieve expected profit on schedule.모든 업데이트 보기Recent updatesBreakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Chairman of the Board Ulf Hagman is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Mar 27+ 3 more updatesOptiCept Technologies AB (publ) to Report Q2, 2026 Results on Aug 28, 2026OptiCept Technologies AB (publ) announced that they will report Q2, 2026 results on Aug 28, 2026공시 • Dec 19Opticept Technologies AB (Publ) Appoints Mikael Carleson and Jörgen Durban as Board MembersOptiCept Technologies AB (publ) at its EGM held on December 18, 2025 appointed Mikael Carleson and Jörgen Durban were elected as new Board members.공시 • Nov 22+ 1 more updateOptiCept Technologies AB (publ) to Report Fiscal Year 2025 Final Results on Mar 27, 2026OptiCept Technologies AB (publ) announced that they will report fiscal year 2025 final results on Mar 27, 2026공시 • Oct 22OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026.공시 • May 29+ 1 more updateOptiCept Technologies AB (publ) to Report Q3, 2025 Results on Nov 27, 2025OptiCept Technologies AB (publ) announced that they will report Q3, 2025 results on Nov 27, 2025공시 • Nov 29OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million.OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million. Security Name: Shares Security Type: Common Stock Securities Offered: 16,092,625 Price\Range: SEK 5 Transaction Features: Rights Offering공시 • Nov 27OptiCept Technologies AB (publ) Expands Project with Dole in ThailandOptiCept has successfully completed its project with Dole in Thailand, which was announced in the spring of 2024. Following positive results, Dole has decided to extend and expand the collaboration to further explore the potential of OptiCept's technology platforms. The focus is now on optimizing the drying process for pineapples. During the initial 14-day pilot period, OptiCept achieved the project goals. The treatment resulted in improved texture in pineapple products, making them more appealing to new markets with high-quality standards. At the same time, an evaluation of the drying process showed significantly increased efficiency through reduced drying times. As a result, Dole wants to conduct further tests to fully map the commercial benefits of PEF (Pulsed Electric Field) technology in the pineapple drying process. The project is therefore entering a commercial phase. Thailand is a globally significant producer of pineapples, with an annual production of approximately 1.2 million tons, placing the country among the top five producers worldwide. Asia is also the world's largest region in terms of both production and consumption of pineapples, making the Thai market a strategic priority for OptiCept.Buy Or Sell Opportunity • Nov 11Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to €0.41. The fair value is estimated to be €0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 749% in 2 years. Earnings are forecast to grow by 93% in the next 2 years.Breakeven Date Change • Oct 21Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 51% per year to 2025. The company is expected to make a profit of kr1.85m in 2026. Average annual earnings growth of 87% is required to achieve expected profit on schedule.Reported Earnings • Oct 19Third quarter 2024 earnings released: kr0.28 loss per share (vs kr0.67 loss in 3Q 2023)Third quarter 2024 results: kr0.28 loss per share (improved from kr0.67 loss in 3Q 2023). Net loss: kr13.1m (loss narrowed 37% from 3Q 2023). Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.New Risk • Oct 18New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: kr67m Forecast net loss in 3 years: kr622k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Currently unprofitable and not forecast to become profitable over next 3 years (kr622k net loss in 3 years). Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€34.0m market cap, or US$36.9m).공시 • Oct 11OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025.New Risk • Oct 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€27.6m market cap, or US$30.3m).공시 • Oct 03Opticept Technologies AB (publ) Announces Chief Financial Officer ChangesOptiCept Technologies AB (publ) announced that OptiCept's Chief Financial Officer, Despina Georgiadou Hedin, has decided to step down from her role. Henrik Nettersand will be the new CFO. Despina Georgiadou Hedin, who has been CFO at OptiCept Technologies since 2023, will leave her position no later than April 2, 2025. Henrik Nettersand, currently CFO at S:t Eriks AB, will succeed her. Henrik Nettersand most recently served as CFO at S:t Eriks AB and will assume his new role no later than April 2, 2025. Previously, he was CFO at Besikta Bilprovning for five years and held several leadership roles during his eleven years at John Bean Technologies AB, including as Head of Finance. He began his career as an auditor at KPMG and holds a Master of Science in Economics and Business Administration from Lund University, with a specialization in finance. Henrik has many years of experience in financial leadership roles, both at the company and group levels, and has extensive global experience. His long experience working with multinational companies in growth, both inside and outside Sweden, and with companies delivering complex food technology globally, has given him the expertise and business focus the company need in its global expansion.New Risk • Sep 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€23.2m market cap, or US$25.8m).Reported Earnings • Aug 30Second quarter 2024 earnings released: kr0.23 loss per share (vs kr0.57 loss in 2Q 2023)Second quarter 2024 results: kr0.23 loss per share (improved from kr0.57 loss in 2Q 2023). Net loss: kr10.3m (loss narrowed 39% from 2Q 2023). Revenue is forecast to grow 48% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Jul 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 153% to €0.59. The fair value is estimated to be €0.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.공시 • Jul 02OptiCept Technologies AB Submits Patent Application and Strengthens Its IP-Portfolio for Vacuum Impregnation Focused on CuttingsOptiCept Technologies AB announced that the company has submitted a patent application to the Swedish Patent and Registration Office (PRV). The patent application includes strengthened and expanded patent protection for the company's vacuum impregnation technology, OptiBoost. OptiCept brings the vacuum infusion platform to the next level by specifying the successful treatment conditions for its plant technology platform, OptiBoost. The patent application encompasses the detailed method of treating the plant material such as cuttings leading to improved rooting. Successes with tests on cuttings have prompted the submission of the patent application. The company learns and develops with every new test. The method that OptiCept uses is mastered, and the knowledge of how to control and implement it is becoming stronger and stronger with new activities and a growing portfolio of tested species.The patent application expounds the exact conditions for applying the vacuum infusion process to achieve the most optimal treatment for plants. The treatment must be mild and well-controlled to minimize the stress applied to the plant tissue, which is ensured by the innovative way of designing the vacuum curve. The patent also describes the correct treatment criteria by controlling the percentage of air removed from the tissue and percentage of liquid incorporated into the tissue by specifying the surface impregnation parameters.Buy Or Sell Opportunity • Jul 01Now 3.4% overvalued after recent price riseOver the last 90 days, the stock has risen 83% to €0.46. The fair value is estimated to be €0.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.Buy Or Sell Opportunity • Jun 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 95% to €0.50. The fair value is estimated to be €0.41, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.Breakeven Date Change • Jun 05Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 60% per year to 2025. The company is expected to make a profit of kr6.00m in 2026. Average annual earnings growth of 82% is required to achieve expected profit on schedule.Reported Earnings • Jun 04First quarter 2024 earnings released: kr0.35 loss per share (vs kr0.71 loss in 1Q 2023)First quarter 2024 results: kr0.35 loss per share (improved from kr0.71 loss in 1Q 2023). Net loss: kr14.7m (loss narrowed 30% from 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.Board Change • May 30Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Anders Hattmark was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.공시 • Apr 12OptiCept Technologies AB Files Patent Application for Combined PEF and VI Treatment of Fruit and Vegetable ProductsOptiCept Technologies AB announced that the company has submitted a new patent application to the Swedish Intellectual Property Office (PRV). The patent application includes a new application area for the company's technologyplatforms CEPT (Controlled Environment PEF treatment) and VI (Vacuum infusion) in fruit and vegetable processing. Success with tests on pineapple chunks has prompted the filing of the patent application. OptiCept has developed a new application area for the company's technology platforms. The patent application includes a Pulsed Electric Field (PEF) step followed by a vacuum injection step, or the steps separately for softening fruit or vegetable products (pieces of fruit or vegetables), where the fruit or vegetable products are impregnated with fruit or vegetable juice to improve product color and texture. This new technology can naturally improve the organoleptic properties of products to be even more appreciated by consumers due to improved texture, consistency, and color. It also creates the conditions to produce completely new products. Success with tests on pineapple chunks has prompted the filing of the patent application.Reported Earnings • Feb 28Full year 2023 earnings released: kr2.48 loss per share (vs kr5.03 loss in FY 2022)Full year 2023 results: kr2.48 loss per share (improved from kr5.03 loss in FY 2022). Net loss: kr80.4m (loss narrowed 20% from FY 2022). Revenue is forecast to grow 41% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Machinery industry in Germany.공시 • Feb 27OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024.공시 • Dec 22OptiCept Technologies AB (publ) Receives First Partial Results from the Pilot Project to Improve the Staining of Cuttings in ChinaOptiCept Technologies AB (publ) announced that it has received the first partial results from the pilot project to improve the rooting of cuttings in China, which initially focuses on Acacia. The root of Acacia cuttings improved by 12-33% depending on the type of Acacia treated. In May 2023, OptiCept Technologies entered an agreement with Guangxi Shichen Group ("GSG"), in collaboration with the Chinese state research institute Guangxi Academy of Forestry, to evaluate the OptiBoost technology on several different types of cuttings to improve its rooting. Acacia cuttings treated with the patented vacuum impregnation technology show an average improved rooting of 12-33% after 45 days, with the final assessment made after 90 days. Results from the evaluation of Camelia will be available in 2024 when tests for Eucalyptus also will be carried out. Acacia is a large genus with many species. Cultivation of Acacia is particularly common in China, Southeast Asia, South America, Africa, and in Australia, where Acacia forest is the second most common forest type after Eucalyptus forest. Acacia is one of the most cultivated trees in the southern hemisphere and is a fast-growing species that can grow in harsh conditions that other species cannot, which can quickly generate yields.Reported Earnings • Nov 30Third quarter 2023 earnings released: kr0.67 loss per share (vs kr1.09 loss in 3Q 2022)Third quarter 2023 results: kr0.67 loss per share (improved from kr1.09 loss in 3Q 2022). Net loss: kr20.7m (loss narrowed 4.4% from 3Q 2022). Revenue is forecast to grow 85% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Machinery industry in Germany.공시 • Nov 30+ 2 more updatesOptiCept Technologies AB (publ) to Report Fiscal Year 2023 Results on Feb 27, 2024OptiCept Technologies AB (publ) announced that they will report fiscal year 2023 results on Feb 27, 2024New Risk • Oct 24New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.39m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Revenue is less than US$1m (kr10m revenue, or US$925k). Market cap is less than US$10m (€9.39m market cap, or US$9.95m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr104m). Currently unprofitable and not forecast to become profitable over next 2 years (kr14m net loss in 2 years).공시 • Oct 22OptiCept Technologies AB (publ) Announces CFO ChangesOptiCept Technologies AB (publ) recruited Déspina Georgiadou Hedin as the company's new CFO. Déspina most recently comes from Ascelia Pharma AB (publ), where she held the position of CFO. She will take up her position no later than 1 November 2023. Déspina Georgiadou Hedin now replaces Tomas Andersson, who acted as interim CFO since April 2023 while a permanent recruitment was carried out. She has extensive experience in leading positions in finance and the role of CFO for both listed and unlisted companies. Most recently, she was the CFO at Ascelia Pharma AB and before that, she was, among other things, CFO and HR manager at Bioglan AB, as well as Chief Accountant and Senior Financial Specialist at Sol Voltaics AB. Déspina has a bachelor's degree in economics from Linnaeus University, Växjö/Kalmar.Reported Earnings • Aug 30Second quarter 2023 earnings released: kr0.57 loss per share (vs kr1.10 loss in 2Q 2022)Second quarter 2023 results: kr0.57 loss per share (improved from kr1.10 loss in 2Q 2022). Net loss: kr17.1m (loss narrowed 22% from 2Q 2022). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Machinery industry in Germany.공시 • Feb 07OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023.Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Breakeven Date Change • Nov 08Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.공시 • Oct 01Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI).Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022. Thomas Lundqvist ill acquire 5300 shares at a price of SEK 28.28. Thomas Lundqvist completed the acquisition of additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022.공시 • May 17Opticept Technologies AB (publ) Announces CEO ChangesOptiCept Technologies' CEO Johan Möllerström has chosen to resign as CEO from the Annual General Meeting on May 25, 2022. The new CEO will be Thomas Lundqvist, who is currently part of the management team as Head of Sales. Johan Möllerström has been CEO of ArcAroma and now OptiCept for 5.5 years and over the years has changed the companies' focus from biogas to food, from freezing processes to cut flowers, and from innovation to commercial success.Reported Earnings • May 09First quarter 2022 earnings released: kr0.74 loss per share (vs kr0.47 loss in 1Q 2021)First quarter 2022 results: kr0.74 loss per share (down from kr0.47 loss in 1Q 2021). Net loss: kr14.8m (loss widened 162% from 1Q 2021). Over the next year, revenue is forecast to grow 4,589%, compared to a 8.9% growth forecast for the industry in Germany.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Apr 02+ 3 more updatesOptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022OptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022.Reported Earnings • Feb 10Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr2.61 loss per share (down from kr1.23 loss in FY 2020). Net loss: kr42.5m (loss widened 199% from FY 2020). Revenue missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 2,568%, compared to a 10% growth forecast for the industry in Germany.Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests the company will make a profit of kr40.0m in 2021. Earnings growth of 89% is required to achieve expected profit on schedule.Reported Earnings • Feb 18Full year 2020 earnings released: kr1.03 loss per share (vs kr0.81 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: kr3.33m (down 40% from FY 2019). Net loss: kr11.9m (loss widened 43% from FY 2019).공시 • Feb 18OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA).OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA) on February 16, 2021. The transaction is subject to shareholders approval of ArcAroma AB (publ). The transaction is approved by the Board of ArcAroma AB (publ).이익 및 매출 성장 예측DB:725 - 애널리스트 향후 추정치 및 과거 재무 데이터 (SEK Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202878151726112/31/202758-269112/31/202641-19-55112/31/202537-90-54-44N/A9/30/202543-53-58-45N/A6/30/202525-47-57-46N/A3/31/202530-57-60-49N/A12/31/202428-56-59-48N/A9/30/202433-60-66-48N/A6/30/202428-67-67-54N/A3/31/202422-74-77-74N/A12/31/202322-80-98-84N/A9/30/202310-101-96-88N/A6/30/202310-101-104-92N/A3/31/202312-106-97-73N/A12/31/202211-100-87-73N/A9/30/20229-79-86-68N/A6/30/202210-71-76-53N/A3/31/20229-56-67-48N/A12/31/20215-47-51-33N/A9/30/20214-36-40-24N/A6/30/20213-24-30-21N/A3/31/20210-20-24-16N/A12/31/20200-14-17-11N/A9/30/20201-7-10-8N/A6/30/20202-7-10-7N/A3/31/20205-6-6-4N/A12/31/20196-8-9-7N/A9/30/20195-7N/A-7N/A6/30/20196-6N/A-6N/A3/31/20193-7N/A-8N/A12/31/20183-7N/A-7N/A9/30/20183-7N/A-6N/A6/30/20182-8N/A-7N/A3/31/20182-9N/A-9N/A12/31/20172-9N/A-8N/A9/30/20171-9N/A-9N/A6/30/20171-9N/A-9N/A3/31/20171-8N/AN/AN/A12/31/20161-7N/A-7N/A9/30/20161-7N/AN/AN/A6/30/20161-6N/AN/AN/A3/31/20161-6N/AN/AN/A12/31/20151-5N/A-4N/A9/30/20151-4N/AN/AN/A6/30/20151-4N/AN/AN/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 725 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(1.9%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: 725 (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: 725 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: 725 의 수익(연간 26.4%)이 German 시장(연간 6.8%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 725 의 수익(연간 26.4%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 725의 자본 수익률은 3년 후 4.9%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YCapital-goods 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 19:35종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스OptiCept Technologies AB (publ)는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Hjalmar JernstromDNB Carnegie Commissioned Research
Breakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.
Breakeven Date Change • Oct 21Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 51% per year to 2025. The company is expected to make a profit of kr1.85m in 2026. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
Breakeven Date Change • Jun 05Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 60% per year to 2025. The company is expected to make a profit of kr6.00m in 2026. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 08Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests the company will make a profit of kr40.0m in 2021. Earnings growth of 89% is required to achieve expected profit on schedule.
Breakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.
Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Chairman of the Board Ulf Hagman is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Mar 27+ 3 more updatesOptiCept Technologies AB (publ) to Report Q2, 2026 Results on Aug 28, 2026OptiCept Technologies AB (publ) announced that they will report Q2, 2026 results on Aug 28, 2026
공시 • Dec 19Opticept Technologies AB (Publ) Appoints Mikael Carleson and Jörgen Durban as Board MembersOptiCept Technologies AB (publ) at its EGM held on December 18, 2025 appointed Mikael Carleson and Jörgen Durban were elected as new Board members.
공시 • Nov 22+ 1 more updateOptiCept Technologies AB (publ) to Report Fiscal Year 2025 Final Results on Mar 27, 2026OptiCept Technologies AB (publ) announced that they will report fiscal year 2025 final results on Mar 27, 2026
공시 • Oct 22OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026.
공시 • May 29+ 1 more updateOptiCept Technologies AB (publ) to Report Q3, 2025 Results on Nov 27, 2025OptiCept Technologies AB (publ) announced that they will report Q3, 2025 results on Nov 27, 2025
공시 • Nov 29OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million.OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million. Security Name: Shares Security Type: Common Stock Securities Offered: 16,092,625 Price\Range: SEK 5 Transaction Features: Rights Offering
공시 • Nov 27OptiCept Technologies AB (publ) Expands Project with Dole in ThailandOptiCept has successfully completed its project with Dole in Thailand, which was announced in the spring of 2024. Following positive results, Dole has decided to extend and expand the collaboration to further explore the potential of OptiCept's technology platforms. The focus is now on optimizing the drying process for pineapples. During the initial 14-day pilot period, OptiCept achieved the project goals. The treatment resulted in improved texture in pineapple products, making them more appealing to new markets with high-quality standards. At the same time, an evaluation of the drying process showed significantly increased efficiency through reduced drying times. As a result, Dole wants to conduct further tests to fully map the commercial benefits of PEF (Pulsed Electric Field) technology in the pineapple drying process. The project is therefore entering a commercial phase. Thailand is a globally significant producer of pineapples, with an annual production of approximately 1.2 million tons, placing the country among the top five producers worldwide. Asia is also the world's largest region in terms of both production and consumption of pineapples, making the Thai market a strategic priority for OptiCept.
Buy Or Sell Opportunity • Nov 11Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to €0.41. The fair value is estimated to be €0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 749% in 2 years. Earnings are forecast to grow by 93% in the next 2 years.
Breakeven Date Change • Oct 21Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 51% per year to 2025. The company is expected to make a profit of kr1.85m in 2026. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
Reported Earnings • Oct 19Third quarter 2024 earnings released: kr0.28 loss per share (vs kr0.67 loss in 3Q 2023)Third quarter 2024 results: kr0.28 loss per share (improved from kr0.67 loss in 3Q 2023). Net loss: kr13.1m (loss narrowed 37% from 3Q 2023). Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.
New Risk • Oct 18New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: kr67m Forecast net loss in 3 years: kr622k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Currently unprofitable and not forecast to become profitable over next 3 years (kr622k net loss in 3 years). Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€34.0m market cap, or US$36.9m).
공시 • Oct 11OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025.
New Risk • Oct 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€27.6m market cap, or US$30.3m).
공시 • Oct 03Opticept Technologies AB (publ) Announces Chief Financial Officer ChangesOptiCept Technologies AB (publ) announced that OptiCept's Chief Financial Officer, Despina Georgiadou Hedin, has decided to step down from her role. Henrik Nettersand will be the new CFO. Despina Georgiadou Hedin, who has been CFO at OptiCept Technologies since 2023, will leave her position no later than April 2, 2025. Henrik Nettersand, currently CFO at S:t Eriks AB, will succeed her. Henrik Nettersand most recently served as CFO at S:t Eriks AB and will assume his new role no later than April 2, 2025. Previously, he was CFO at Besikta Bilprovning for five years and held several leadership roles during his eleven years at John Bean Technologies AB, including as Head of Finance. He began his career as an auditor at KPMG and holds a Master of Science in Economics and Business Administration from Lund University, with a specialization in finance. Henrik has many years of experience in financial leadership roles, both at the company and group levels, and has extensive global experience. His long experience working with multinational companies in growth, both inside and outside Sweden, and with companies delivering complex food technology globally, has given him the expertise and business focus the company need in its global expansion.
New Risk • Sep 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€23.2m market cap, or US$25.8m).
Reported Earnings • Aug 30Second quarter 2024 earnings released: kr0.23 loss per share (vs kr0.57 loss in 2Q 2023)Second quarter 2024 results: kr0.23 loss per share (improved from kr0.57 loss in 2Q 2023). Net loss: kr10.3m (loss narrowed 39% from 2Q 2023). Revenue is forecast to grow 48% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Jul 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 153% to €0.59. The fair value is estimated to be €0.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.
공시 • Jul 02OptiCept Technologies AB Submits Patent Application and Strengthens Its IP-Portfolio for Vacuum Impregnation Focused on CuttingsOptiCept Technologies AB announced that the company has submitted a patent application to the Swedish Patent and Registration Office (PRV). The patent application includes strengthened and expanded patent protection for the company's vacuum impregnation technology, OptiBoost. OptiCept brings the vacuum infusion platform to the next level by specifying the successful treatment conditions for its plant technology platform, OptiBoost. The patent application encompasses the detailed method of treating the plant material such as cuttings leading to improved rooting. Successes with tests on cuttings have prompted the submission of the patent application. The company learns and develops with every new test. The method that OptiCept uses is mastered, and the knowledge of how to control and implement it is becoming stronger and stronger with new activities and a growing portfolio of tested species.The patent application expounds the exact conditions for applying the vacuum infusion process to achieve the most optimal treatment for plants. The treatment must be mild and well-controlled to minimize the stress applied to the plant tissue, which is ensured by the innovative way of designing the vacuum curve. The patent also describes the correct treatment criteria by controlling the percentage of air removed from the tissue and percentage of liquid incorporated into the tissue by specifying the surface impregnation parameters.
Buy Or Sell Opportunity • Jul 01Now 3.4% overvalued after recent price riseOver the last 90 days, the stock has risen 83% to €0.46. The fair value is estimated to be €0.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.
Buy Or Sell Opportunity • Jun 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 95% to €0.50. The fair value is estimated to be €0.41, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.
Breakeven Date Change • Jun 05Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 60% per year to 2025. The company is expected to make a profit of kr6.00m in 2026. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
Reported Earnings • Jun 04First quarter 2024 earnings released: kr0.35 loss per share (vs kr0.71 loss in 1Q 2023)First quarter 2024 results: kr0.35 loss per share (improved from kr0.71 loss in 1Q 2023). Net loss: kr14.7m (loss narrowed 30% from 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.
Board Change • May 30Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Anders Hattmark was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
공시 • Apr 12OptiCept Technologies AB Files Patent Application for Combined PEF and VI Treatment of Fruit and Vegetable ProductsOptiCept Technologies AB announced that the company has submitted a new patent application to the Swedish Intellectual Property Office (PRV). The patent application includes a new application area for the company's technologyplatforms CEPT (Controlled Environment PEF treatment) and VI (Vacuum infusion) in fruit and vegetable processing. Success with tests on pineapple chunks has prompted the filing of the patent application. OptiCept has developed a new application area for the company's technology platforms. The patent application includes a Pulsed Electric Field (PEF) step followed by a vacuum injection step, or the steps separately for softening fruit or vegetable products (pieces of fruit or vegetables), where the fruit or vegetable products are impregnated with fruit or vegetable juice to improve product color and texture. This new technology can naturally improve the organoleptic properties of products to be even more appreciated by consumers due to improved texture, consistency, and color. It also creates the conditions to produce completely new products. Success with tests on pineapple chunks has prompted the filing of the patent application.
Reported Earnings • Feb 28Full year 2023 earnings released: kr2.48 loss per share (vs kr5.03 loss in FY 2022)Full year 2023 results: kr2.48 loss per share (improved from kr5.03 loss in FY 2022). Net loss: kr80.4m (loss narrowed 20% from FY 2022). Revenue is forecast to grow 41% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Machinery industry in Germany.
공시 • Feb 27OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024.
공시 • Dec 22OptiCept Technologies AB (publ) Receives First Partial Results from the Pilot Project to Improve the Staining of Cuttings in ChinaOptiCept Technologies AB (publ) announced that it has received the first partial results from the pilot project to improve the rooting of cuttings in China, which initially focuses on Acacia. The root of Acacia cuttings improved by 12-33% depending on the type of Acacia treated. In May 2023, OptiCept Technologies entered an agreement with Guangxi Shichen Group ("GSG"), in collaboration with the Chinese state research institute Guangxi Academy of Forestry, to evaluate the OptiBoost technology on several different types of cuttings to improve its rooting. Acacia cuttings treated with the patented vacuum impregnation technology show an average improved rooting of 12-33% after 45 days, with the final assessment made after 90 days. Results from the evaluation of Camelia will be available in 2024 when tests for Eucalyptus also will be carried out. Acacia is a large genus with many species. Cultivation of Acacia is particularly common in China, Southeast Asia, South America, Africa, and in Australia, where Acacia forest is the second most common forest type after Eucalyptus forest. Acacia is one of the most cultivated trees in the southern hemisphere and is a fast-growing species that can grow in harsh conditions that other species cannot, which can quickly generate yields.
Reported Earnings • Nov 30Third quarter 2023 earnings released: kr0.67 loss per share (vs kr1.09 loss in 3Q 2022)Third quarter 2023 results: kr0.67 loss per share (improved from kr1.09 loss in 3Q 2022). Net loss: kr20.7m (loss narrowed 4.4% from 3Q 2022). Revenue is forecast to grow 85% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Machinery industry in Germany.
공시 • Nov 30+ 2 more updatesOptiCept Technologies AB (publ) to Report Fiscal Year 2023 Results on Feb 27, 2024OptiCept Technologies AB (publ) announced that they will report fiscal year 2023 results on Feb 27, 2024
New Risk • Oct 24New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.39m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Revenue is less than US$1m (kr10m revenue, or US$925k). Market cap is less than US$10m (€9.39m market cap, or US$9.95m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr104m). Currently unprofitable and not forecast to become profitable over next 2 years (kr14m net loss in 2 years).
공시 • Oct 22OptiCept Technologies AB (publ) Announces CFO ChangesOptiCept Technologies AB (publ) recruited Déspina Georgiadou Hedin as the company's new CFO. Déspina most recently comes from Ascelia Pharma AB (publ), where she held the position of CFO. She will take up her position no later than 1 November 2023. Déspina Georgiadou Hedin now replaces Tomas Andersson, who acted as interim CFO since April 2023 while a permanent recruitment was carried out. She has extensive experience in leading positions in finance and the role of CFO for both listed and unlisted companies. Most recently, she was the CFO at Ascelia Pharma AB and before that, she was, among other things, CFO and HR manager at Bioglan AB, as well as Chief Accountant and Senior Financial Specialist at Sol Voltaics AB. Déspina has a bachelor's degree in economics from Linnaeus University, Växjö/Kalmar.
Reported Earnings • Aug 30Second quarter 2023 earnings released: kr0.57 loss per share (vs kr1.10 loss in 2Q 2022)Second quarter 2023 results: kr0.57 loss per share (improved from kr1.10 loss in 2Q 2022). Net loss: kr17.1m (loss narrowed 22% from 2Q 2022). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Machinery industry in Germany.
공시 • Feb 07OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023.
Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Breakeven Date Change • Nov 08Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
공시 • Oct 01Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI).Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022. Thomas Lundqvist ill acquire 5300 shares at a price of SEK 28.28. Thomas Lundqvist completed the acquisition of additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022.
공시 • May 17Opticept Technologies AB (publ) Announces CEO ChangesOptiCept Technologies' CEO Johan Möllerström has chosen to resign as CEO from the Annual General Meeting on May 25, 2022. The new CEO will be Thomas Lundqvist, who is currently part of the management team as Head of Sales. Johan Möllerström has been CEO of ArcAroma and now OptiCept for 5.5 years and over the years has changed the companies' focus from biogas to food, from freezing processes to cut flowers, and from innovation to commercial success.
Reported Earnings • May 09First quarter 2022 earnings released: kr0.74 loss per share (vs kr0.47 loss in 1Q 2021)First quarter 2022 results: kr0.74 loss per share (down from kr0.47 loss in 1Q 2021). Net loss: kr14.8m (loss widened 162% from 1Q 2021). Over the next year, revenue is forecast to grow 4,589%, compared to a 8.9% growth forecast for the industry in Germany.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Apr 02+ 3 more updatesOptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022OptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022.
Reported Earnings • Feb 10Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr2.61 loss per share (down from kr1.23 loss in FY 2020). Net loss: kr42.5m (loss widened 199% from FY 2020). Revenue missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 2,568%, compared to a 10% growth forecast for the industry in Germany.
Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests the company will make a profit of kr40.0m in 2021. Earnings growth of 89% is required to achieve expected profit on schedule.
Reported Earnings • Feb 18Full year 2020 earnings released: kr1.03 loss per share (vs kr0.81 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: kr3.33m (down 40% from FY 2019). Net loss: kr11.9m (loss widened 43% from FY 2019).
공시 • Feb 18OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA).OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA) on February 16, 2021. The transaction is subject to shareholders approval of ArcAroma AB (publ). The transaction is approved by the Board of ArcAroma AB (publ).